反应 #1253198

ord-714f6de46dbb4bbaaa83e5d001cdc20b

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    温度After cooling to −70°
  2. 2
    workup.WAITcontinued at −70° for 15 minutes
  3. 3
    workup.WAITto rise to 20-25° over 16 hours
  4. 4
    其他The organic phase is separated
  5. 5
    萃取extracted into ethyl acetate (3×25 ml)
  6. 6
    洗涤washed with saline
  7. 7
    干燥dried over magnesium sulfate
  8. 8
    其他The solvent is removed
  9. 9
    其他the residue purified by chromatography (silica
  10. 10
    洗涤eluting with
  11. 11
    温度a gradient increasing in polarity from 0 to 3% methanol in dichloromethane)

实验过程

A solution of lithium t-butoxide is prepared by addition of n-butyllithium (1.6 M in hexane, 2.9 ml) to a stirred solution of t-butanol (0.43 g) in anhydrous THF (10 ml) at −10° under argon. After cooling to −70°, a solution of 5-benzyloxycarbonylamino-2-(4-[2 fluoroethyl]-3-oxopiperazin-1-yl)fluorobenzene (1.5 g) in dry THF (15 ml) is added. After 10 minutes, (R)-glycidylbutyrate (0.67 g) in dry THF (15 ml) is added to the resulting mixture, and stirring continued at −70° for 15 minutes, before allowing the temperature to rise to 20-25° over 16 hours. Methanol (10 ml) is added, followed by saturated sodium bicarbonate solution (20 ml) and water (10 ml). The organic phase is separated and extracted into ethyl acetate (3×25 ml), washed with saline and dried over magnesium sulfate. The solvent is removed and the residue purified by chromatography (silica; eluting with a gradient increasing in polarity from 0 to 3% methanol in dichloromethane) to give (5R)-3-(3-fluoro-4-[4-(2-fluoroethyl)-3-oxopiperazin-1-yl]phenyl)-5 hydroxymethyloxazolidin-2-one.

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US06613349B2uspto-grants-2003_09